The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Two targets and five ambitious gender equality results are aligned with the new World Bank Corporate Scorecard. Delivering on the ambition of the new WBG Gender Strategy requires engaging differently.